SE8406202L - Framstellning av penicillansyraderivat - Google Patents

Framstellning av penicillansyraderivat

Info

Publication number
SE8406202L
SE8406202L SE8406202A SE8406202A SE8406202L SE 8406202 L SE8406202 L SE 8406202L SE 8406202 A SE8406202 A SE 8406202A SE 8406202 A SE8406202 A SE 8406202A SE 8406202 L SE8406202 L SE 8406202L
Authority
SE
Sweden
Prior art keywords
compounds
beta
formula
preparation
acid derivatives
Prior art date
Application number
SE8406202A
Other languages
English (en)
Other versions
SE462097B (sv
SE8406202D0 (sv
Inventor
Daehne W Von
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of SE8406202L publication Critical patent/SE8406202L/sv
Publication of SE8406202D0 publication Critical patent/SE8406202D0/sv
Publication of SE462097B publication Critical patent/SE462097B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8406202A 1979-05-21 1984-12-06 Foerfarande foer framstaellning av en i huvudsak ren 6 beta-halogen penicillansyra SE462097B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB7917665 1979-05-21
GB7930819 1979-09-05
GB7941252 1979-11-29
GB8006681 1980-02-27

Publications (3)

Publication Number Publication Date
SE8406202L true SE8406202L (sv) 1984-12-06
SE8406202D0 SE8406202D0 (sv) 1984-12-06
SE462097B SE462097B (sv) 1990-05-07

Family

ID=27449123

Family Applications (3)

Application Number Title Priority Date Filing Date
SE8003722A SE452465B (sv) 1979-05-21 1980-05-19 6 beta-halopenicillansyraderivat och kompositioner innehallande desamma
SE8406201A SE462096B (sv) 1979-05-21 1984-12-06 Dicyklohexylammonium-6 beta-brompenicillanat vilken aer anvaendbar saasom mellanprodukt
SE8406202A SE462097B (sv) 1979-05-21 1984-12-06 Foerfarande foer framstaellning av en i huvudsak ren 6 beta-halogen penicillansyra

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SE8003722A SE452465B (sv) 1979-05-21 1980-05-19 6 beta-halopenicillansyraderivat och kompositioner innehallande desamma
SE8406201A SE462096B (sv) 1979-05-21 1984-12-06 Dicyklohexylammonium-6 beta-brompenicillanat vilken aer anvaendbar saasom mellanprodukt

Country Status (19)

Country Link
US (3) US4446144A (sv)
JP (1) JPS55154977A (sv)
AU (3) AU534754B2 (sv)
BE (1) BE883390A (sv)
CA (1) CA1265787A (sv)
DE (3) DE3051037C2 (sv)
DK (2) DK158669C (sv)
FI (1) FI801618A (sv)
FR (2) FR2457294A1 (sv)
GR (1) GR68372B (sv)
IE (2) IE49768B1 (sv)
IL (1) IL59948A0 (sv)
IT (1) IT1133091B (sv)
LU (1) LU82468A1 (sv)
NL (1) NL8002911A (sv)
NZ (1) NZ193597A (sv)
PH (2) PH17959A (sv)
PT (1) PT71273A (sv)
SE (3) SE452465B (sv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4432970A (en) * 1979-11-23 1984-02-21 Pfizer Inc. 6-beta-Halopenicillanic acid 1,1-dioxides as beta-lactamase inhibitors
IE51846B1 (en) * 1980-11-17 1987-04-15 Leo Pharm Prod Ltd Pharmaceutical preparation for veterinary use and an appliance containing it
US4521533A (en) * 1984-07-12 1985-06-04 Pfizer Inc. Salts of 6-alpha-(aminomethyl)penicillanic acid 1,1-dioxide esters and beta-lactam antibiotics
GB8522156D0 (en) * 1985-09-06 1985-10-09 Leo Pharm Prod Ltd Producing chemical compounds
US5695951A (en) * 1994-12-20 1997-12-09 Biopure Corporation Chlorination of cephalexin with chloroperoxidase from Rathayibacter biopuresis
US5589354A (en) * 1994-12-20 1996-12-31 Biopure Corporation Halogenation of cephalexin with haloperoxidase from Rathayibacter biopuresis
ATE223201T1 (de) 1996-12-18 2002-09-15 Bimeda Res & Dev Ltd Infektionsfreie intramammäre tierarzneimittelzusammenstellung
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
MXPA05004219A (es) * 2002-10-25 2005-06-08 Akzo Nobel Nv Composicion farmaceutica de liberacion prolongada.
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004025324A1 (de) * 2004-05-19 2005-12-08 Boehringer Ingelheim Vetmedica Gmbh Flüssige Zubereitung für die Veterinärmedizin, Verfahren zu deren Herstellung und deren Verwendung
SI2874624T1 (sl) * 2012-07-17 2020-02-28 Bayer New Zealand Limited Formulacije antibiotikov za injektiranje in postopek njihove uporabe
CN104507475B (zh) * 2012-07-17 2019-03-22 拜耳新西兰有限公司 注射用抗生素制剂及其使用方法
EP2934524B1 (en) * 2012-12-20 2019-03-27 Alleva Animal Health Limited Penethamate veterinary injectable formulations
EP4265241A1 (en) * 2022-04-20 2023-10-25 Bilim Ilac Sanayii Ve Ticaret A.S. Tablet formulations for the treatment of urinary system infections and method for the preparation of such formulations

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1089385B (de) 1954-06-21 1960-09-22 Biochemie Gmbh Verfahren zur Herstellung von in Wasser schwer loeslichen, besonders fuer die Oraltherapie geeigneten Salzen des Penicillins mit organischen Basen
DE1031795B (de) 1955-09-29 1958-06-12 Chimiotherapie Lab Franc Verfahren zur Herstellung eines Salzes aus Penicillin und einer Piperazinbase
US3206469A (en) * 1961-08-15 1965-09-14 Lepetit Spa 6-halopenicillanic acid
GB1297555A (sv) * 1970-09-22 1972-11-22
GB1377817A (en) * 1971-06-09 1974-12-18 Beecham Group Ltd Penicillins and cephalosporins
IN149747B (sv) * 1977-06-07 1982-04-03 Pfizer
US4234579A (en) * 1977-06-07 1980-11-18 Pfizer Inc. Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
US4180506A (en) * 1978-01-18 1979-12-25 Rex Pratt 6β-Bromo penicillanic acid
CA1158639A (en) 1978-12-11 1983-12-13 Eric M. Gordon 6-bromopenicillanic acid sulfone
US4203992A (en) * 1978-12-11 1980-05-20 E. R. Squibb & Sons, Inc. β-Bromopenicillanic acid sulfone
IL59081A0 (en) * 1979-01-10 1980-05-30 Schering Corp 2-penem compounds and a method for preparing them
DE3068390D1 (en) * 1979-01-10 1984-08-09 Beecham Group Plc Penicillin derivatives, process for their preparation and pharmaceutical compositions containing certain of these compounds
US4518530A (en) * 1979-03-05 1985-05-21 Pfizer Inc. 6-β-Substituted penicillanic acids as β-lactamase inhibitors
US4397783A (en) * 1979-03-05 1983-08-09 Pfizer Inc. Process for converting 6,6-disubstituted penicillanic acid derivatives to the 6-β-congeners
US4287181A (en) * 1979-10-22 1981-09-01 Pfizer Inc. Derivatives of 6β-hydroxyalkylpenicillanic acids as β-lactamase inhibitors
US4432970A (en) * 1979-11-23 1984-02-21 Pfizer Inc. 6-beta-Halopenicillanic acid 1,1-dioxides as beta-lactamase inhibitors

Also Published As

Publication number Publication date
US4594246A (en) 1986-06-10
AU541322B2 (en) 1985-01-03
DK562589D0 (da) 1989-11-10
IE49768B1 (en) 1985-12-11
DE3051038A1 (sv) 1986-03-20
DK562589A (da) 1989-11-10
DK158669C (da) 1991-01-21
SE462096B (sv) 1990-05-07
DK158670B (da) 1990-07-02
FR2499575A1 (fr) 1982-08-13
IE842559L (en) 1980-11-21
LU82468A1 (fr) 1980-12-16
US4446144A (en) 1984-05-01
DE3019244A1 (de) 1980-12-04
PH17959A (en) 1985-02-20
DE3019244C2 (sv) 1989-04-06
SE462097B (sv) 1990-05-07
AU5858480A (en) 1980-11-27
BE883390A (fr) 1980-11-20
FR2457294A1 (fr) 1980-12-19
DK218580A (da) 1980-11-22
AU1848783A (en) 1983-12-22
NL8002911A (nl) 1980-11-25
AU1848683A (en) 1983-12-22
DE3051037C2 (sv) 1989-03-30
DK158669B (da) 1990-07-02
AU534754B2 (en) 1984-02-16
JPS55154977A (en) 1980-12-02
CA1265787A (en) 1990-02-13
IE49770B1 (en) 1985-12-11
FR2499575B1 (sv) 1985-03-01
PH19005A (en) 1985-12-03
SE452465B (sv) 1987-11-30
IT1133091B (it) 1986-07-09
AU541323B2 (en) 1985-01-03
GR68372B (sv) 1981-12-28
FI801618A (fi) 1980-11-22
SE8406201L (sv) 1984-12-06
SE8406202D0 (sv) 1984-12-06
FR2457294B1 (sv) 1984-01-13
IT8067790A0 (it) 1980-05-20
JPH0140837B2 (sv) 1989-08-31
US4672114A (en) 1987-06-09
IE800868L (en) 1980-11-21
SE8003722L (sv) 1980-11-22
SE8406201D0 (sv) 1984-12-06
DK158670C (da) 1991-01-07
IL59948A0 (en) 1980-06-30
PT71273A (en) 1980-06-01
NZ193597A (en) 1985-04-30
DE3051038C2 (sv) 1989-04-13

Similar Documents

Publication Publication Date Title
SE8406202D0 (sv) Framstellning av penicillansyraderivat
EP0946176B1 (de) Verwendung von 7-(2-oxa-5,8-diazabicyclo 4.3.0]non-8-yl)-chinoloncarbonsäure- und -naphthyridoncarbonsäure-derivaten zur herstellung eines arzneimittels zur therapie von helicobacter-pylori-infektionen und den damit assoziierten gastroduodenalen erkrankungen
PT828724E (pt) Diaril-5-oxigenadas-2-(5h)-furanonas comoinibidoras de cox-2
JPS5557572A (en) Diphenylbutyllpiperazinecarboxamide and carbothioamide*its acid addition salt*its manufacture and medical composition containing it
DD149529A5 (de) Verfahren zur herstellung von neuen beta-lactamverbindungen
PT76336B (de) Cephalosporinderivate und verfahren zu ihrer herstellung
PT77125A (en) Process for preparing triphenylimidazolyloxy-alkanoic acids and their derivatives and of pharmaceutical compositions containing these compounds
SE7707462L (sv) Forfarande for framstellning av penicillansyraderivat
DE2967356D1 (en) Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them
DE3367215D1 (en) Pyridobenzodiazepinones, process for their preparation and pharmaceutical compositions containing them
HU901570D0 (en) Process for the preparation of azetidinyl-pyridonecarboxylic acid derivatives and pharmaceutical compositions containing such compounds
ZA826453B (en) Tricyclic thiazolyloxamic acids and their derivatives,their preparation,and therapeutic agents containing these compounds
FI893677A (sv) Förfarande för framställning av terapeutiskt användbara 6-fluor-3,5-dihydroxikarboxylsyror och deras derivat
IL64839A (en) N-arylmethyl-4-(methylanilino)-5-sulfamoyl-anthranilic acids,a process for their preparation and pharmaceutical compositions containing them
FI885172A0 (sv) Förfarande för framställning av terapeutiskt användbara, substituerade tienoimidazolderivat
ES8302721A1 (es) Un procedimiento para la preparacion de derivados de cefa- losporina

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8406202-5

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8406202-5

Format of ref document f/p: F